Matinas BioPharma Holdings, Inc.
MTNB
$0.5571
-$0.0429-7.15%
AMEX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -24.58% | 76.49% | -41.04% | -24.48% | -19.09% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -2.82% | -56.69% | 22.57% | 0.81% | 19.90% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Current Assets | -23.19% | 48.56% | -33.80% | -22.24% | -16.71% |
|
|
|||||
| Total Current Assets | -23.19% | 48.56% | -33.80% | -22.24% | -16.71% |
| Net Property, Plant & Equipment | -5.39% | -5.05% | -4.79% | -4.59% | -4.08% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -15.55% | 24.25% | -21.88% | -15.73% | -12.44% |
|
|
|||||
| Total Accounts Payable | 46.64% | -49.68% | -7.98% | -38.44% | 38.25% |
| Total Accrued Expenses | -28.09% | 71.87% | -42.02% | -17.64% | 28.06% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.65% | 3.79% | 3.78% | 3.77% | 3.92% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -11.20% | 19.72% | -23.80% | -18.80% | 24.72% |
|
|
|||||
| Total Current Liabilities | -11.20% | 19.72% | -23.80% | -18.80% | 24.72% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.75% | -6.78% | -6.29% | -5.73% | -5.25% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | -8.82% | 4.16% | -13.76% | -11.79% | 7.62% |
|
|
|||||
| Common Stock & APIC | 0.44% | 5.19% | 0.54% | 0.66% | 0.62% |
| Retained Earnings | -2.28% | -3.15% | -3.32% | -3.12% | -3.69% |
| Treasury Stock & Other | -- | 61.94% | 39.37% | 38.44% | 30.16% |
| Total Common Equity | -17.40% | 31.22% | -24.36% | -16.86% | -16.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.40% | 31.22% | -24.36% | -16.86% | -16.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.40% | 31.22% | -24.36% | -16.86% | -16.89% |
|
|
|||||